haleon.com (HLN) Short-Term Debt to Equity

haleon.com - graphic logo of issuer HLN

Haleon plc relies on a global network of plants located near key target markets to ensure stable supplies. The short-term debt to equity trend demonstrates current liquidity, with the parameter reaching 0.10. Strong brands such as Sensodyne and Theraflu, along with a reduction in debt load, are driving the rise in share prices. The regionalization of production minimizes maritime shipping, guaranteeing the constant availability of products in pharmacies.

Short-Term Debt to Equity Ratio: Haleon PLC (HLN) for 04/28/2023 - 11/01/2026
Product sample of Haleon

This indicator reflects the dependence of short-term liabilities on equity volume, determining the business's liquidity. The metric measures the company's need for operational borrowings of up to one year relative to its net assets. For Haleon plc (HLN), the reduction of this burden, backed by the strength of the Sensodyne and Theraflu brands, confirms financial stability. The trend in the ratio of current loans to equity demonstrates the effectiveness of the deleveraging strategy and readiness for expansion.

Key competitors

Short-Term Debt to Capital KVUE|Short-Term Debt to Capital Verona Pharma Inc. (VRNA)|Short-Term Debt to Equity Jyong Biotech Ltd MENS|Ratio of Short-Term Indebtedness to Capital LGND|AMRX - Short-Term Debt to Equity|Perrigo Company PLC (PRGO) - Short-Term Debt to Equity Ratio|ALVO: Short-Term Debt to Capital|Liquidia Inc. (LQDA) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio GLPG|ANIP: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity MannKind (MNKD)|AMPH - Current Liabilities to Capital|Pacira - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio SPRY (ARS Corp)|Theravance Biopharma - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital AQST (aquestive.com)|SCPH: Short-Term Debt to Capital|Current Liabilities to Capital Tectonic Therapeutic (TECX)|Short-Term Debt to Equity Tonix Pharmaceuticals Inc.|SXTC: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital EPRX|BHST (bioharvest.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital EXOZ (eXoZymes)|Short-Term Debt to Capital Oramed ORMP|ENTX - Short-Term Debt to Equity|HYFT: Short-Term Debt to Equity|ABVC: Short-Term Debt to Capital|Current Liabilities to Capital cumberlandpharma.com (CPIX)|Short-Term Debt to Equity Quantum BioPharma|Current Liabilities to Capital FibroGen Inc FGEN|Short-Term Debt to Equity Telomir Pharma (TELO)|ranitherapeutics.com - Short-Term Debt to Capital Ratio|Synergy CHC - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital RLYB|LEXX - Short-Term Debt to Equity|Current Liabilities to Equity PULM|ftzy.com.cn (PTHL) - Short-Term Debt to Equity|APM (Aptorum Group) - Short-Term Debt to Equity|LYRA (Lyra Therapeutics, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio impactbiomedinc.com (IBO)|Short-Term Debt to Capital TNFA|YCBD (cbdmd.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity PainReform Limited PRFX|Altamira Therapeutics Ltd - Short-Term Debt to Equity|LIPO - Short-Term Debt to Equity|OPTN (optinose.com) - Short-Term Debt to Capital Ratio|Pieris Pharmaceuticals, Inc. (PIRS) - Short-Term Debt to Equity|Current Liabilities to Equity PROC (Procaps Group)|PTPI (Petros) - Short-Term Debt to Capital|QLI: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital SLRN|Short-Term Debt to Capital tffpharma.com (TFFP)